A case of thyroid hormone resistance: Prospective follow-up during pregnancy and obstetric outcome

European Journal of Internal Medicine

Volumn 18, Issue 3, 2007, Pages 253-254

  Massaad, Dany ^a   Poppe, Kris ^a   Lissens, Willy ^a   Velkeniers, Brigitte ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Mutation; Pregnancy; Resistance to thyroid hormone; Thyroid hormone receptor beta

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DELIVERY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; PREGNANCY OUTCOME; PROSPECTIVE STUDY; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RESISTANCE;

EID: 34247146842     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.09.030     Document Type: Article

References (6)

1. Weiss R.E., and Refetoff S. Treatment of resistance to thyroid hormone-Primium Non Nocere. J Clin Endocrinol Metab 84 (1999) 401-404
2. Beck-Peccoz P., and Chatterjee V.K. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4 (1994) 225-232
3. Refetoff S., Weiss R.E., and Usala S.J. The syndromes of resistance to thyroid hormone. Endocr Rev 14 (1993) 348-399
4. Collingwood T.N., Wagner R., Mattheus C.H., et al. A role for helix 3 of the TR beta ligand-binding domain in coactivator recruitment identified by characterisation of a third cluster of mutations in resistance to thyroid hormone. EMBO J 17 16 (1998) 4760-4770
5. Anselmo J., Cao D., Karrison T., Weiss R.E., and Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 292 (2004)
6. Yagi H., Pohlenz J., Hayashi Y., Sakurai A., and Refetoff S. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3′-triiodothyroinine binding affinity. J Clin Endocrinol Metab 82 5 (May 1997) 1608-1614